Target intelligence / Profile preview

Leucine-rich repeat-containing protein 74A (LRRC74A)

Target
LRRC74A
Molecular classification
Other (leucine-rich repeat-containing structural protein)
01

Overview

Leucine-rich repeat-containing protein 74A (LRRC74A) is a cytoplasmic protein encoded by the LRRC74A gene on chromosome 14q24.3. It is comprised of 488 amino acids, with a predicted molecular weight of ~55 kDa and an isoelectric point of 5.22. The protein features eight leucine-rich repeat domains, a hallmark structure supporting protein-protein interactions, and has structural similarity to ribonuclease inhibitor proteins. LRRC74A is most highly expressed in the testis, salivary gland, and pancreas, though at generally low levels. Mutations in LRRC74A have been associated with increased mortality in COVID-19 and associations with twin-to-twin transfusion syndrome and primary ciliary dyskinesia. Although its precise biological role is not fully characterized, its structural features suggest a function in intracellular protein interactions; in some model organisms, it is predicted to bind calcium ions. There are currently no known drugs or targeted therapies acting on LRRC74A, and it is not classified as a therapeutic target.

Other names
C14orf166BLRRC74leucine rich repeat containing 74ALeucine-rich repeat-containing protein 74leucine-rich repeat-containing protein 74Aleucine rich repeat containing 74LRRC74A
02

Biological functions

Protein-protein interactioncytosolic structural functionpossible calcium ion binding
03

Disease associations

COVID-19 (mutation associated with higher mortality)Twin-to-twin transfusion syndromePrimary ciliary dyskinesia
04

Biomarkers

Mutation in LRRC74A gene as biomarker for increased COVID-19 mortality risk

Beyond the preview

Go deeper on Leucine-rich repeat-containing protein 74A (LRRC74A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine-rich repeat-containing protein 74A (LRRC74A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call